Overview

Antihypertensive Efficacy of Fixed Combination Drug

Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
Treatment and control of hypertension is still insufficient. About 50% of the patients remain uncontrolled. Lack of compliance with discontinuation of drug treatment is an important reason for not achieving blood pressure. Several studies have shown that use of fixed combinations improve compliance significantly, by reducing the number of pill's intake. This study will assess the antihypertensive efficacy of Vasodip-Combo 20® [enalapril 20 mg + lercanidipine 10 mg] as a fixed combination drug in uncontrolled antihypertensive patients.
Phase:
Phase 4
Details
Lead Sponsor:
Meir Medical Center
Collaborator:
Dexcel Pharma Technologies Ltd.
Treatments:
Enalapril
Enalaprilat
Lercanidipine